0 Commentarii
0 Distribuiri
5 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
- Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
- Drug Substance and Drug Product Segments Drive Growth in the Global Pharmaceutical CDMO MarketThe global pharmaceutical contract development & manufacturing organization (CDMO) market, valued at USD 192.19 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 8.11% through 2034, driven by intensifying regional disparities in regulatory frameworks, supply chain localization mandates, and strategic capacity reallocation. North America continues to dominate...0 Commentarii 0 Distribuiri 504 Views 0 previzualizare
- Global Recombinant protein therapeutics CDMO Market : Market Scope and Opportunities 2032The Recombinant Protein Therapeutics CDMO Market is gaining substantial momentum as pharmaceutical and biotechnology companies increasingly outsource complex biologics manufacturing to specialized contract development and manufacturing organizations (CDMOs). Valued at USD 20,920.32 million in 2024, the market is projected to expand at a robust CAGR of 13.98% from 2025 to 2032. Growth is driven...0 Commentarii 0 Distribuiri 157 Views 0 previzualizare
- Large Molecule Drug Substance CDMO Market by Service Type, End-User, and Region 2025–2034The global large molecule drug substance CDMO market was valued at approximately USD 51.89 billion in 2024 and is forecast to expand at a CAGR of 7.64 % from 2025 through 2034, reflecting accelerating outsourcing of biologics production and development across pharmaceutical and biotechnology value chains. Rapid uptake of monoclonal antibodies, biosimilars and other large-molecule therapeutics...0 Commentarii 0 Distribuiri 527 Views 0 previzualizare
- Regional Insights: North America and Europe Lead the Peptide and Oligonucleotide CDMO MarketA new growth forecast report titled Peptide and Oligonucleotide CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Peptides, Oligonucleotides); By Service; By End User; By Region; Segment Forecast, 2024- 2032 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide a detailed analysis of growth factors,...0 Commentarii 0 Distribuiri 442 Views 0 previzualizare
- U.S. Large Molecule Drug Substance CDMO Market Analysis 2025–2034: Segment-Wise and Country-Wise PerspectivesThe U.S. large molecule drug substance CDMO market continues to reinforce its strategic position within the global biopharmaceutical value chain, with the market valued at USD 12.34 billion in 2024 and expanding at a projected CAGR of 7.5% from 2025 to 2034. This growth trajectory reflects the rising reliance of biopharma developers on external partners for biologics development,...0 Commentarii 0 Distribuiri 355 Views 0 previzualizare
© 2026 La Lingua Nostra
Romaian